CARBOPLATIN (CBDCA, JM-8) AND VP-16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER

被引：95
作者：
BISHOP, JF
RAGHAVAN, D
STUARTHARRIS, R
MORSTYN, G
ARONEY, R
KEFFORD, R
YUEN, K
LEE, J
GIANOUTSOS, P
OLVER, IN
ZALCBERG, J
BALL, D
BULL, C
FOX, R
机构：
[1] LUDWIG INST CANC RES,CH-1066 EPALINGES,SWITZERLAND
[2] ROYAL MELBOURNE HOSP,PARKVILLE,VIC 3050,AUSTRALIA
[3] ROYAL PRINCE ALFRED HOSP,CAMPERDOWN,NSW 2050,AUSTRALIA
[4] UNIV SYDNEY,WESTMEAD CTR,WESTMEAD,NSW 2145,AUSTRALIA
[5] REPATRIAT GEN HOSP,MELBOURNE,AUSTRALIA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 10期
关键词：
D O I：
10.1200/JCO.1987.5.10.1574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1574 / 1578
页数：5
相关论文
共 20 条
[1]  
AISNER J, 1982, CANCER TREAT REP, V66, P221
[2]   CARBOPLATIN - THE CLINICAL SPECTRUM TO DATE [J].
CANETTA, R ;
ROZENCWEIG, M ;
CARTER, SK .
CANCER TREATMENT REVIEWS, 1985, 12 :125-136
[3]   PHASE-II STUDY WITH CIS-DICHLORODIAMMINEPLATINUM-(II) IN SMALL CELL ANAPLASTIC BRONCHOGENIC-CARCINOMA [J].
CAVALLI, F ;
GOLDHIRSCH, A ;
SIEGENTHALER, P ;
KAPLAN, S ;
BEER, M .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (05) :617-621
[4]  
DIXON WJ, 1981, BMDP STATISTICAL SOF, P330
[5]  
DOMBERNOWSKY P, 1979, CANCER TREAT REP, V63, P543
[6]  
EGORIN MJ, 1984, CANCER RES, V44, P5432
[7]  
EVANS W K, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P169
[8]   ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER [J].
EVANS, WK ;
OSOBA, D ;
FELD, R ;
SHEPHERD, FA ;
BAZOS, MJ ;
DEBOER, G .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) :65-71
[9]  
Harrap K.R., 1980, CISPLATIN CURRENT ST, P193, DOI 10.1016/B978-0-12-565050-2.50016-4
[10]   PRECLINICAL STUDIES ON TOXICITY, ANTITUMOUR ACTIVITY AND PHARMACOKINETICS OF CISPLATIN AND 3 RECENTLY DEVELOPED DERIVATIVES [J].
LELIEVELD, P ;
VANDERVIJGH, WJF ;
VELDHUIZEN, RW ;
VANVELZEN, D ;
VANPUTTEN, LM ;
ATASSI, G ;
DANGUY, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08) :1087-1104
12